glp-1 for pcos weight loss Management GLP-1s For PCOS: What the

Patients receiving telitacicept, particularly at a dosage of 240 mg weekly, experienced a substantial reduction in proteinuria, with a mean decrease of 49% from baseline, which was statistically significant compared to the placebo group (P = 0.013)

Tirzepatide, a dual glucagon-like peptide-1 (GIP) and GLP-1RAs, administered once weekly at a 15 mg dose, resulted in an average weight loss of 20.9% over 72 weeks (Jastreboff et al., 2022), driven by its synergistic effects on appetite regulation, energy intake reduction, and fat mass decrease (Heise et al., 2023)

* Uso tpico o externo solamente

Neviere R, Fauvel H, Chopin C, Formstecher P, Marchetti P

Much of this evidence comes from preclinical models, so human conclusions remain limited

(14) CJC-1295 & Ipamorelin peptide blend is available for research and laboratory purposes only